Blandt patienter med psoriasis artrit, som fik Enbrel, var den kliniske respons tydelig på tidspunktet for første besøg (4 uger) og blev opretholdt gennem 6 måneders behandling.
Among patients with psoriatic arthritis who received Enbrel, the clinical responses were apparent at the time of the first visit (4 weeks) and were maintained through 6 months of therapy.